Evidence item

The study reports no statistically distinguishable susceptibility difference, with adjusted odds ratio 0.97 and 95% confidence interval 0.81–1.16. DATASET_RESULT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 15958

Source: Metformin use and decreased risk of severe COVID-19 outcomes in a real-world case-control study · locator {} · excerpt hash sha256:df4e62472e432c97f64fd8881d4208abbd8e4d3cf800c40bf852250543d814ec

There were no differences in risk of susceptibility to the SARS-CoV-2 virus (aOR 0.97; 95%CI 0.81–1.16).